Venkataraman Ramesh, Divatia Jigeeshu V, Ramakrishnan Nagarajan, Chawla Rajesh, Amin Pravin, Gopal Palepu, Chaudhry Dhruva, Zirpe Kapil, Abraham Babu
Department of Critical Care Medicine, Apollo Hospitals, Chennai, Tamil Nadu, India.
Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Indian J Crit Care Med. 2018 Jan;22(1):20-26. doi: 10.4103/ijccm.IJCCM_394_17.
There is limited data regarding the microbiology of Intensive Care Unit (ICU)-acquired infections, such as ventilator-associated pneumonia (VAP), catheter-associated urinary tract infections (CAUTI), and catheter-related bloodstream infections (CRBSI) from India.
To explore the microbiology and resistance patterns of ICU-acquired infections and evaluate their outcomes.
This was a multicenter observational study, conducted by Indian Society of Critical Care Medicine (MOSER study) between August 2011 and October 2012. Patients in the ICU ≥48 h with any ICU-acquired infection within 14 days of index ICU stay were included. Patient demographics, relevant clinical, and microbiological details were collected. Follow-up until hospital discharge or death was done, and 6-month survival data were collected.
Of the 381 patients included in the study, 346 patients had 1 ICU infection and 35 had more than one ICU infection. Among patients with single infections, 223 had VAP with Acinetobacter being the most common isolate. CAUTI was seen in 42 patients with as the most common organism. CRBSI was seen in 81 patients and was the most common causative organism. Multidrug resistance was noted in 87.5% of Acinetobacter, 75.5% of , 61.9% of , and 58.9% of isolates, respectively. constituted only 2.4% of isolates. Mortality rates were 26%, 11.9%, and 34.6% in VAP, CAUTI, and CRBSI, respectively.
VAP is the most common infection followed by CRBSI and CAUTI. Multidrug-resistant Gram-negative bacteria are the most common organisms. is uncommon in the Indian setting.
关于印度重症监护病房(ICU)获得性感染的微生物学数据有限,如呼吸机相关性肺炎(VAP)、导管相关性尿路感染(CAUTI)和导管相关血流感染(CRBSI)。
探讨ICU获得性感染的微生物学及耐药模式,并评估其转归。
这是一项多中心观察性研究,由印度危重病医学会于2011年8月至2012年10月开展(MOSER研究)。纳入在ICU住院≥48小时且在入住ICU后14天内发生任何ICU获得性感染的患者。收集患者的人口统计学、相关临床和微生物学详细信息。随访至出院或死亡,并收集6个月生存数据。
在纳入研究的381例患者中,346例患者发生1次ICU感染,35例患者发生1次以上ICU感染。在单次感染患者中,223例发生VAP,不动杆菌是最常见的分离菌。42例患者发生CAUTI, 是最常见的病原体。81例患者发生CRBSI, 是最常见的致病病原体。分别有87.5%的不动杆菌、75.5%的 、61.9%的 和58.9%的分离株呈现多重耐药。 仅占分离株的2.4%。VAP、CAUTI和CRBSI的死亡率分别为26%、11.9%和34.6%。
VAP是最常见的感染,其次是CRBSI和CAUTI。多重耐药革兰阴性菌是最常见的病原体。 在印度的情况下不常见。